Home
>
National Drug Code (NDC)
>
Zipsor
Zipsor - 13913-008-11 - (diclofenac potassium)
Drug Information of Zipsor
| Product NDC: | 13913-008 |
| Proprietary Name: | Zipsor |
| Non Proprietary Name: | diclofenac potassium |
| Active Ingredient(s): | 25 mg/1 & nbsp; diclofenac potassium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, LIQUID FILLED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Zipsor
| Product NDC: | 13913-008 |
| Labeler Name: | Depomed, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022202 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100430 |
Package Information of Zipsor
| Package NDC: | 13913-008-11 |
| Package Description: | 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (13913-008-11) |
NDC Information of Zipsor
| NDC Code | 13913-008-11 |
| Proprietary Name | Zipsor |
| Package Description | 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (13913-008-11) |
| Product NDC | 13913-008 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | diclofenac potassium |
| Dosage Form Name | CAPSULE, LIQUID FILLED |
| Route Name | ORAL |
| Start Marketing Date | 20100430 |
| Marketing Category Name | NDA |
| Labeler Name | Depomed, Inc. |
| Substance Name | DICLOFENAC POTASSIUM |
| Strength Number | 25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
